Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature
Authors
Keywords
-
Journal
JOURNAL DE MYCOLOGIE MEDICALE
Volume 33, Issue 3, Pages 101414
Publisher
Elsevier BV
Online
2023-07-24
DOI
10.1016/j.mycmed.2023.101414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open‐label randomized controlled trial
- (2023) Valliappan Muthu et al. MYCOSES
- Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
- (2022) Valliappan Muthu et al. LANCET INFECTIOUS DISEASES
- A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia
- (2022) Jiaojiao Zhang et al. Annals of Translational Medicine
- Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis
- (2021) Valliappan Muthu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects
- (2021) H. Yesid Estupiñán et al. Frontiers in Cell and Developmental Biology
- Role of flexible bronchoscopy in the diagnosis of invasive fungal infections
- (2021) Valliappan Muthu et al. MYCOSES
- Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)
- (2021) Pau Abrisqueta et al. Clinical Lymphoma Myeloma & Leukemia
- Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap
- (2021) Cornelia Geisler Crone et al. JOURNAL DE MYCOLOGIE MEDICALE
- Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns
- (2020) Gemma Reynolds et al. LEUKEMIA & LYMPHOMA
- Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemia
- (2019) A. Pouvaret et al. CLINICAL MICROBIOLOGY AND INFECTION
- Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies
- (2019) Kerry A. Rogers et al. LEUKEMIA
- The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy
- (2019) Marco A. Mascarella et al. Journal of Otolaryngology-Head & Neck Surgery
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
- (2019) J Peter Donnelly et al. CLINICAL INFECTIOUS DISEASES
- Azole antifungals and new targeted therapies for hematological malignancy
- (2019) Julian Lindsay et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
- (2018) David Ghez et al. BLOOD
- Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies
- (2018) Benjamin F. Tillman et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts
- (2018) Saira Ajmal et al. INFECTION
- Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib
- (2018) Kaelyn C. Cummins et al. LEUKEMIA & LYMPHOMA
- Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report
- (2018) O. Grossi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma
- (2017) Natalia Kreiniz et al. HEMATOLOGICAL ONCOLOGY
- ID: 54: CUTANEOUS MUCORMYCOSIS IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A PHARMACOLOGICAL DILEMMA
- (2016) CE Figueroa Castro JOURNAL OF INVESTIGATIVE MEDICINE
- Fungal Infection by Mucorales Order in Lung Transplantation: 4 Case Reports
- (2014) F.M.F.D. Neto et al. TRANSPLANTATION PROCEEDINGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started